Insights

Acquisition Advantage Xcelience is now part of Capsugel, signaling a broader suite of capsule and dosage form capabilities that can be cross-sold to Capsugel’s existing biopharma and consumer health customers.

Capsugel Synergy Leverage Capsugel’s design, development and manufacturing expertise to bundle end-to-end solutions, potentially expanding into integrated formulation, capsule polymer science and process design services for new and existing clients.

Mid-market Focus With a lean team and revenue in the lower mid-market range, there is room to scale by targeting faster-growing biotech and contract manufacturing organizations seeking flexible, rapid development for diverse dosage forms.

Specialized Capabilities Capitalize on Xcelience’s formulation know-how and proprietary technologies to upsell advanced delivery solutions, bioavailability optimization and patient-centric dosage forms to customers pursuing competitive product profiles.

Strategic Upsell Position as a premium, integrated solution provider within Capsugel’s ecosystem to pursue cross-sell opportunities across biopharma and consumer health segments, leveraging capsule science leadership to win multi-dose projects.

Similar companies to Xcelience (Acquired by Capsugel)

Xcelience (Acquired by Capsugel)'s Email Address Formats

Xcelience (Acquired by Capsugel) uses at least 3 email formats:
Xcelience (Acquired by Capsugel) Email FormatsExamplePercentage
First.Last@xcelience.comJohn.Doe@xcelience.com
88%
FLast@xcelience.comJDoe@xcelience.com
10%
Last@xcelience.comDoe@xcelience.com
2%

Frequently Asked Questions

What is Xcelience (Acquired by Capsugel)'s phone number?

Minus sign iconPlus sign icon
You can contact Xcelience (Acquired by Capsugel)'s main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Xcelience (Acquired by Capsugel)'s official website and social media links?

Minus sign iconPlus sign icon
Xcelience (Acquired by Capsugel)'s official website is xcelience.com and has social profiles on LinkedIn.

How much revenue does Xcelience (Acquired by Capsugel) generate?

Minus sign iconPlus sign icon
As of August 2026, Xcelience (Acquired by Capsugel)'s annual revenue is estimated to be $25M - $50M.

What is Xcelience (Acquired by Capsugel)'s NAICS code?

Minus sign iconPlus sign icon
Xcelience (Acquired by Capsugel)'s NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Xcelience (Acquired by Capsugel) have currently?

Minus sign iconPlus sign icon
As of August 2026, Xcelience (Acquired by Capsugel) has approximately 25 employees across 1 continents, including North America. Key team members include Head Of Public Services: L. F., Director Of Communications: A. H. and Director , New Business Development: J. M. Explore Xcelience (Acquired by Capsugel)'s employee directory with LeadIQ.

What industry does Xcelience (Acquired by Capsugel) belong to?

Minus sign iconPlus sign icon
Xcelience (Acquired by Capsugel) operates in the Pharmaceutical Manufacturing industry.

What is Xcelience (Acquired by Capsugel)'s email format?

Minus sign iconPlus sign icon
Xcelience (Acquired by Capsugel)'s email format typically follows the pattern of First.Last@xcelience.com. Find more Xcelience (Acquired by Capsugel) email formats with LeadIQ.

When was Xcelience (Acquired by Capsugel) founded?

Minus sign iconPlus sign icon
Xcelience (Acquired by Capsugel) was founded in 1997.
Xcelience (Acquired by Capsugel) logo

Xcelience (Acquired by Capsugel)

Pharmaceutical ManufacturingFlorida, United States11-50 Employees

Xcelience, now part of Capsugel, operates in the pharmaceutical manufacturing space and is based in Tampa, Florida. Through its integration with Capsugel, the entity contributes to designing, developing, and producing dosage forms for biopharmaceutical and consumer health and nutrition markets. The collaboration emphasizes improving bioavailability, targeted delivery, and overall product performance across a range of dosage forms.

Its customers are in the biopharmaceutical and consumer health and nutrition sectors, seeking customized dosage-form solutions that fit evolving product profiles and development timelines. A recent development is Xcelience's integration into Capsugel, reflecting a continuation of dosage-form design and production capabilities under Capsugel.

Section iconCompany Overview

Phone number
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
1997
Employees
11-50

Section iconFunding & Financials

  • $25M - $50M

    Xcelience (Acquired by Capsugel)'s revenue is estimated to be in the range of $25M - $50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.